Delivery Order SPE2DB22D1041-SPE2DB23FP5ST
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,993.50 firm fixed-price delivery order is for the medication AMLOD-VALSA-HCTZ 10-320-25 MG 30S, with a completion date of June 26, 2025. The contract is not set aside and allows for the supply of a range of pharmaceutical products and medical supplies to support military healthcare programs worldwide....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $7,532.17 firm-fixed-price delivery order is for the supply of AMLOD-VALSA-HCTZ 10-320-25 MG 30S medication. This contract is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,158.86 firm fixed-price contract is for the delivery of AMLOD-VALSA-HCTZ 10-320-25 MG 30S medical supplies. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of AMLOD-VALSA-HCTZ 10-320-25 MG 30S medication. The $1,598.19 Firm Fixed Price contract has an ultimate completion date of October 18, 2024. This award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. The IDC, which runs through...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $15,055.71, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999. The IDC, which runs through November 2026, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,773.34, is a delivery order for the supply of AMLOD-VALSA-HCTZ 10-320-25 MG 30S, a pharmaceutical product. The contract has an ultimate completion date of February 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,654.18 firm fixed-price delivery order covers the supply of AMLOD-VALSA-HCTZ 10-320-25 MG medication in 30-count packages. The contract has a completion date of February 26, 2025 and was awarded on February 25, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,574.36 fixed-price delivery order contract, awarded on March 6, 2025, is for the delivery of AMLOD-VALSA-HCTZ 10-160-12.5MG 30S, a type of pharmaceutical product, with a completion date of March 7, 2025. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,003.51 firm fixed price delivery order is for the pharmaceutical product AMLOD-VALSA-HCTZ 5-160-12.5 MG 30S. This award does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 2025, which serves as...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA). The $2,590.80 firm fixed-price delivery order is for the supply of AMLOD-VALSA-HCTZ 10-160-25 MG 30S, a cardiovascular medication, to support military healthcare programs. The award is not associated with a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB23FP5STDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,453.31 firm fixed-price delivery order is for the supply of AMLOD-VALSA-HCTZ 10-320-25 MG 30S medication and has a performance period ending on May 16, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 5/15/23 |